Sign In
Buy TLTFF
$0.166
+0.0001 (+0.0602%)
At Close: Jun 23, 2026
Theralase Launches First Clinical Study Site in the US for Phase II Bladder Cancer Clinical Study
07:00am, Tuesday, 19'th Jan 2021
TORONTO, ON / ACCESSWIRE / January 19, 2021 / Theralase® Technologies Inc. ("Theralase" or "Company") (TSXV:TLT)(OTCQB:TLTFF), a clinical stage pharmaceutical company focused on the research and deve
